BackgroundCheck.run
Search For

Xiao T Zhou, 5713609 Red Squirrel Way, Herndon, VA 20171

Xiao Zhou Phones & Addresses

13609 Red Squirrel Way, Herndon, VA 20171   

2553 Chase Wellesley Dr, Herndon, VA 20171    703-9557863   

Oak Hill, VA   

302 Prettyman Dr, Rockville, MD 20850    301-5450307    302-3251718   

19 Highland Blvd, New Castle, DE 19720    302-3251718   

Allston, MA   

Fairfax, VA   

Work

Company: Ming X Zhou MD Address: 932 Hungerford Dr Suite 11A, Rockville, MD 20850 Phones: 301-8388551 (Phone)

Education

School / High School: Peking University Med College Peking China 1983

Languages

English • Chinese

Mentions for Xiao T Zhou

Career records & work history

Medicine Doctors

Xiao Zhou Photo 1

Dr. Xiao M Zhou, Rockville MD - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
Ming X Zhou MD
932 Hungerford Dr Suite 11A, Rockville, MD 20850
301-8388551 (Phone)
Languages:
English
Chinese
Hospitals:
Ming X Zhou MD
932 Hungerford Dr Suite 11A, Rockville, MD 20850
Baltimore Washington Medical Center
301 Hospital Drive, Glen Burnie, MD 21061
Greater Baltimore Medical Center
6701 North Charles Street, Towson, MD 21204
MedStar Good Samaritan Hospital
5601 Loch Raven Boulevard, Baltimore, MD 21239
Shady Grove Adventist Hospital
9901 Medical Center Drive, Rockville, MD 20850
University of Maryland St. Joseph Medical Center
7601 Osler Drive, Towson, MD 21204
Education:
Medical School
Peking University Med College Peking China
Graduated: 1983

Xiao M. Zhou

Specialties:
Internal Medicine
Work:
Ming X Zhou MD
932 Hungerford Dr STE 11A, Rockville, MD 20850
301-8388551 (phone)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1983
Procedures:
Electrocardiogram (EKG or ECG), Vaccine Administration
Conditions:
Acute Upper Respiratory Tract Infections, Anemia, Benign Prostatic Hypertrophy, Calculus of the Urinary System, Cardiac Arrhythmia, Chronic Renal Disease, Constipation, Dementia, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Gout, Heart Failure, Hemorrhoids, Herpes Zoster, Hypertension (HTN), Hypothyroidism, Infectious Liver Disease, Insomnia, Ischemic Heart Disease, Ischemic Stroke, Non-Toxic Goiter, Osteoporosis, Peripheral Nerve Disorders, Transient Cerebral Ischemia, Varicose Veins, Vitamin D Deficiency, Abnormal Vaginal Bleeding, Acne, Acute Bronchitis, Acute Conjunctivitis, Acute Myocardial Infarction (AMI), Acute Pancreatitis, Acute Pharyngitis, Acute Renal Failure, Acute Sinusitis, Alcohol Dependence, Alopecia Areata, Alzheimer's Disease, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Aortic Valvular Disease, Atherosclerosis, Atopic Dermatitis, Atrial Fibrillation and Atrial Flutter, Bacterial Pneumonia, Bell's Palsy, Benign Thyroid Diseases, Bipolar Disorder, Bronchial Asthma, Candidiasis, Cardiomyopathy, Cataract, Cholelethiasis or Cholecystitis, Chronic Bronchitis, Chronic Fatigue Syndrome, Cirrhosis, Contact Dermatitis, Dehydration, Depressive Disorders, Dermatitis, Diverticulitis, Diverticulosis, Epilepsy, Erectile Dysfunction (ED), Esophagitis, Fractures, Dislocations, Derangement, and Sprains, Gastritis and Duodenitis, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Hemorrhage, Glaucoma, Hemolytic Anemia, Hemorrhagic stroke, Herpes Simplex, HIV Infection, Hyperthyroidism, Inflammatory Bowel Disease (IBD), Inguinal Hernia, Internal Derangement of Knee Cartilage, Internal Derangement of Knee Ligaments, Intestinal Obstruction, Intracranial Injury, Irritable Bowel Syndrome (IBS), Keratitis, Lateral Epicondylitis, Lyme Disease, Malignant Neoplasm of Female Breast, Melanoma, Menopausal and Postmenopausal Disorders, Migraine Headache, Multiple Sclerosis (MS), Obstructive Sleep Apnea, Osteoarthritis, Osteomyelitis, Otitis Media, Overweight and Obesity, Parkinson's Disease, Paroxysmal Supreventricular Tachycardia (PSVT), Peptic Ulcer Disease, Plantar Fascitis, Pneumonia, Prostatitis, Psoriasis, Pulmonary Embolism, Rheumatoid Arthritis, Rotator Cuff Syndrome and Allied Disorders, Schizophrenia, Sciatica, Septicemia, Skin and Subcutaneous Infections, Spinal Stenosis, Substance Abuse and/or Dependency, Thyroiditis, Urinary Incontinence, Uterine Leiomyoma, Valvular Heart Disease, Venous Embolism and Thrombosis, Vitamin B12 Deficiency Anemia
Languages:
Chinese, English
Description:
Dr. Zhou graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1983. He works in Rockville, MD and specializes in Internal Medicine.

License Records

Xiao Zhou

Licenses:
License #: 2643 - Active
Category: Landscape Architect
Issued Date: Jun 10, 2010
Expiration Date: Sep 30, 2017
Organization:
Firm Not Published

Xiao Zhou resumes & CV records

Resumes

Xiao Zhou Photo 35

Risk Cons

Location:
Washington, DC
Industry:
Financial Services
Work:
Freddie Mac Jun 2004 - Mar 2011
Risk Manager
Wells Fargo Jun 2004 - Mar 2011
Risk Cons
Juniper Financial May 2001 - Jun 2003
Fraud Risk Mananger
First Usa Sep 1999 - May 2001
Financial Analyst
Education:
Penn State University 1997 - 1999
Master of Science, Masters
Lousiana State University 1991 - 1993
Masters, Master of Arts, Education
Peking University 1985 - 1991
Skills:
Portfolio Management, Operational Risk Management, Credit, Financial Analysis, Risk Management, Financial Risk, Mortgage Lending, Credit Analysis, Sas, Banking, Credit Risk, Loans, Investments, Asset Managment, Asset Management, Financial Modeling, Fixed Income, Analysis, Fraud
Interests:
Hiking
Sports
Rhythmic Gymnastics
Xiao Zhou Photo 36

Co-Founder, President

Industry:
Public Relations And Communications
Work:
America-China Bridge
Co-Founder, President
Xiao Zhou Photo 37

Xiao Fang Zhou

Xiao Zhou Photo 38

Xiao Zhou

Xiao Zhou Photo 39

Xiao Hong Zhou

Xiao Zhou Photo 40

Xiao Ning Zhou

Xiao Zhou Photo 41

Xiao Zhou

Skills:
Mba
Xiao Zhou Photo 42

Associate At The Office Of James Burnett

Position:
Associate at The Office of James Burnett
Location:
Solana Beach, California
Industry:
Design
Work:
The Office of James Burnett - San Diego since Aug 2011
Associate
AECOM Jun 2010 - Aug 2010
Intern as assistant landscape architect
Beijing Forestry University Sep 2004 - Jul 2008
BLA Student
Education:
Department of Landscape Architecture & Regional Planning, University of Massachusetts Amherst 2009 - 2011
Master, Landscape Architecture
School of Landscape architecture, Beijing Forestry University 2004 - 2008
Bachelor, Landscape Architecture
Skills:
AutoCAD, Photoshop, ArcGIS, Rendering, InDesign, PowerPoint, Illustrator, Microsoft Word, Microsoft Excel, Chinese, Public Speaking, Modeling, Programming
Interests:
Photograph, Sketching & Design, Running, Movie, Animation, Travelling
Honor & Awards:
Second Price of the 5th Ed Bacon Student Competition - Ed Bacon Foundation 2010 (http://www.edbacon.org/usa250/winners.htm) Third Price of Student Competition - IFLA APR 2009

Publications & IP owners

Us Patents

Methods And Compositions For Regulating Protein-Protein Interactions

US Patent:
6495376, Dec 17, 2002
Filed:
Feb 18, 1999
Appl. No.:
09/252404
Inventors:
Kun Ping Lu - Newton MA
Xiao Zhen Zhou - Newton MA
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
G01N 33566
US Classification:
436501, 435 4, 435 71, 435 76, 435 772, 435 793, 435 794, 435 795, 530300, 530350
Abstract:
The invention relates to methods and compositions of WW-domains as phosphoserine and phosphothreonine binding modules. The WW-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that modulated interactions between WW-domain containing polypeptides and phosphorylated ligands; as drug targeting vehicles; to direct protein degradation; and in the treatment of certain diseases or conditions characterized by aberrant WW-domain containing polypeptides or their ligands.

Pin1 As A Marker For Abnormal Cell Growth

US Patent:
8129131, Mar 6, 2012
Filed:
Jul 18, 2008
Appl. No.:
12/218838
Inventors:
Kun Ping Lu - Newton MA, US
Xiao Zhen Zhou - Newton MA, US
Gerburg Wulf - Cambridge MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
G01N 33/53
US Classification:
435 723
Abstract:
Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In one embodiment, the method includes detecting a level of Pin1 to stage an abnormal cell growth, such as breast or prostate cancer. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the method includes evaluating the extent of metastasis of abnormal cell growth, such as cancer. The levels of Pin1 can be protein levels or nucleic acid levels.

Pin1 As A Marker For Abnormal Cell Growth

US Patent:
2002002, Feb 28, 2002
Filed:
Nov 29, 2000
Appl. No.:
09/726464
Inventors:
Kun Lu - Newton MA, US
Gerburg Wulf - Cambridge MA, US
Xiao Zhou - Newton MA, US
International Classification:
C12Q001/68
G01N033/574
US Classification:
435/006000, 435/007230
Abstract:
Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In one embodiment, the method includes detecting a level of Pin1 to stage an abnormal cell growth, such as breast or prostate cancer. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the method includes evaluating the extent of metastasis of abnormal cell growth, such as cancer. The levels of Pin1 can be protein levels or nucleic acid levels.

Methods And Compositions For Regulating Protein-Protein Interactions

US Patent:
2003004, Mar 13, 2003
Filed:
Sep 26, 2002
Appl. No.:
10/256865
Inventors:
Kun Lu - Newton MA, US
Xiao Zhou - Newton MA, US
Assignee:
Beth Israel Deaconess Medical Center
International Classification:
C12Q001/70
C12Q001/68
G01N033/53
US Classification:
435/006000, 435/005000, 435/007100
Abstract:
The invention relates to methods and compositions of WW-domains as phosphoserine and phosphothreonine binding modules. The WW-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that modulated interactions between WW-domain containing polypeptides and phosphorylated ligands; as drug targeting vehicles; to direct protein degradation; and in the treatment of certain diseases or conditions characterized by aberrant WW-domain containing polypeptides or their ligands.

Novel Telomerase Inhibitors And Uses Therefor

US Patent:
2004014, Jul 22, 2004
Filed:
Nov 10, 2003
Appl. No.:
10/705531
Inventors:
Kun Lu - Newton MA, US
Xiao Zhou - Newton MA, US
Assignee:
Beth Israel Deaconess Medical Center
International Classification:
C12Q001/68
C07H021/04
C12N009/99
US Classification:
435/006000, 435/069200, 435/184000, 435/320100, 435/325000, 530/388260, 536/023200
Abstract:
The present invention provides molecules including Pin2 and telomerase binding polypeptides, polynucleotides encoding such polypeptides, and antibodies specifically immunoreactive to said polypeptides. The invention also provides methods for screening agents which modulate the function or expression of said Pin2 and telomerase binding polypeptides. Methods are provided for disease diagnosis and treatment using said agents, said antibodies and oligonucleotides derived from the above polynucleotides.

Pin1 As A Marker For Abnormal Cell Growth

US Patent:
2005018, Aug 25, 2005
Filed:
Oct 9, 2003
Appl. No.:
10/683880
Inventors:
Kun Lu - Newton MA, US
Gerburg Wulf - Cambridge MA, US
Xiao Zhou - Newton MA, US
International Classification:
G01N033/574
US Classification:
435007230
Abstract:
Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In one embodiment, the method includes detecting a level of Pin1 to stage an abnormal cell growth, such as breast or prostate cancer. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the method includes evaluating the extent of metastasis of abnormal cell growth, such as cancer. The levels of Pin1 can be protein levels or nucleic acid levels.

Methods And Compositions For Regulating Protein-Protein Interactions

US Patent:
2005028, Dec 22, 2005
Filed:
Dec 21, 2004
Appl. No.:
11/022308
Inventors:
Kun Lu - Newton MA, US
Xiao Zhou - Newton MA, US
International Classification:
A61K038/17
US Classification:
514007000
Abstract:
The invention relates to methods and compositions of WW-domains as phosphoserine and phosphothreonine binding modules. The WW-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that modulated interactions between WW-domain containing polypeptides and phosphorylated ligands; as drug targeting vehicles; to direct protein degradation; and in the treatment of certain diseases or conditions characterized by aberrant WW-domain containing polypeptides or their ligands.

Alzheimer's Disease Therapeutics Based On Pin-1 Catalyzed Conformational Changes In Phosphorylated Amyloid Precursor Protein

US Patent:
2008005, Mar 6, 2008
Filed:
Jan 16, 2007
Appl. No.:
11/623672
Inventors:
Kun LU - Newton MA, US
Linda NICHOLSON - Ithaca NY, US
Lucia PASTORINO - Boston MA, US
Xiao ZHOU - Newton MA, US
Soumya DE - Ithaca NY, US
Assignee:
CORNELL RESEARCH FOUNDATION, INC. - Ithaca NY
BETH ISRAEL DEACONESS MEDICAL CENTER - Boston MA
International Classification:
A61K 31/70
A61P 25/28
C12N 5/06
C12Q 1/02
G01N 33/00
US Classification:
514044000, 435029000, 435375000, 436086000
Abstract:
The present invention is directed to inhibiting amyloidogenic processing of amyloid precursor protein, and/or inhibiting production of amyloid beta peptides. These methods can involve accelerating cis/trans isomerization of amyloid precursor protein at a phosphorylated serine/threonine-proline motif and/or contacting a cell with a compound that mimics the cis conformation of a phosphorylated serine/threonine-proline motif of an amyloid precursor protein. The present invention also relates to treating and/or preventing in a subject a degenerative neurological disease characterized by amyloidogenic processing of amyloid precursor protein and/or overproduction of amyloid beta peptide. This method involves administering an agent that accelerates cis/trans isomerization of amyloid precursor protein at a phosphorylated serine/threonine-proline motif and/or inhibits production of amyloid β peptides. Methods of screening for therapeutic agents effective in treating and/or preventing such diseases, methods of screening for biological molecules involved in the amyloidogenic pathway, and compounds that mimic the cis conformation of a phosphorylated serine/threonine-proline motif of an amyloid precursor protein are also disclosed.

Isbn (Books And Publications)

Statistical Methods In Diagnostic Medicine

Author:
Xiao Hua Zhou
ISBN #:
0471347728

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.